logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10881623 B1

PDFFull Text
Date of Patent:
Jan. 05, 2021

Filed:

Dec. 26, 2018

Compositions for the management of hyperglycemia and related conditions

Applicants:

Muhammed Majeed, Edison, NJ (US);

Kalyanam Nagabhushanam, East Windsor, NJ (US);

Lakshmi Mundkur, Bangalore, IN;

Inventors:

Muhammed Majeed, Edison, NJ (US);

Kalyanam Nagabhushanam, East Windsor, NJ (US);

Lakshmi Mundkur, Bangalore, IN;

Assignee:

SAMI LABS LIMITED, Bangalore, IN;

Attorney:
Primary Examiner:

Shaojia A Jiang

Assistant Examiner:

Michael C Henry

Int. Cl.
CPC ...
A61K 31/065 (2006.01); A61K 31/05 (2006.01); A61K 36/71 (2006.01); A61K 47/22 (2006.01); A61K 47/14 (2017.01); A61K 31/191 (2006.01); A61K 31/704 (2006.01); B01D 11/02 (2006.01); A61K 31/122 (2006.01); A61K 47/12 (2006.01); A61P 39/06 (2006.01); A61P 3/10 (2006.01); A61P 29/00 (2006.01); A61K 31/19 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/065 (2013.01); A61K 31/122 (2013.01); A61K 31/19 (2013.01); A61K 31/191 (2013.01); A61K 31/704 (2013.01); A61K 36/71 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61P 3/10 (2018.01); A61P 29/00 (2018.01); A61P 39/06 (2018.01); B01D 11/0203 (2013.01); B01D 11/0288 (2013.01); A61K 2236/00 (2013.01); B01D 11/0211 (2013.01); B01D 11/0292 (2013.01);
Abstract

Disclosed is a method for therapeutic management of hyperglycemia in mammals using compositions containing thymohydroquinone. More specifically, the invention discloses compositions containing thymohydroquinone for inhibiting the activity of the enzyme α-glucosidase and increasing the cellular uptake of glucose by mammalian cells. The anti-oxidant, anti-inflammatory and anti-glycation effects of thymohydroquinone are also disclosed herein.

Find Patent Forward Citations

Majeed, Muhammed. (2021). Compositions for the management of hyperglycemia and related conditions (U.S. Patent No. 10881623). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10881623

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…